CLOSEClose New Jersey Law Journal Menu

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Blister packs containing Lamictal anti-epileptic tablets Blister packs containing Lamictal anti-epileptic tablets, produced by GlaxoSmithKline Plc, sit on a pharmacy counter in London. Photographer: Chris Ratcliffe/Bloomberg

A federal appeals court has overturned a decision certifying a price-fixing class action over a deal to postpone sales of a generic version of GlaxoSmithKline’s epilepsy drug Lamictal.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Charles Toutant

Charles Toutant is a litigation writer for the New Jersey Law Journal.

More from this author


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.